BI-836858 is a fully humanized IgG1 anti-CD33 monoclonal antibody. It is modified at the Fc fragment to enhance binding with FcgammaRIIIa (CD16). BI-836858 exhibits antibody-dependent cellular cytotoxicity (ADCC) activity and is utilized in research related to acute myeloid leukemia (AML).
Target-Kategorie:
Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
